Abstract
Quinolones are a family of synthetic broad-spectrum antimicrobial drugs. These molecules have been widely prescribed to treat various infectious diseases and have been classified into several generations based on their spectrum of activity. Quinolones inhibit bacterial DNA synthesis by interfering with the action of DNA gyrase and topoisomerase IV. Mutations in the genes encoding these targets are the most common mechanisms of high-level fluoroquinolone resistance. Moreover, three mechanisms for plasmid-mediated quinolone resistance (PMQR) have been discovered since 1998 and include Qnr proteins, the aminoglycoside acetyltransferase AAC(6′)-Ib-cr, and plasmid-mediated efflux pumps QepA and OqxAB. Plasmids with these mechanisms often encode additional antimicrobial resistance (extended spectrum beta-lactamases [ESBLs] and plasmidic AmpC [pAmpC] ß-lactamases) and can transfer multidrug resistance. The PMQR determinants are disseminated in Mediterranean countries with prevalence relatively high depending on the sources and the regions, highlighting the necessity of long-term surveillance for the future monitoring of trends in the occurrence of PMQR genes.
Similar content being viewed by others
References
Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP (1962) 1,8-naphthyridine derivatives. a new class of chemotherapeutic agents. J Med Chem 5:1063–1065
Naeem A, Badshah SL, Muska M, Ahmad N, Khan K (2016) The current case of quinolones: synthetic approaches and antibacterial activity. Molecules 21:268
Jacoby GA (2005) Mechanisms of resistance to quinolones. Clin Infect Dis 41:120–126
Jacoby GA, Strahilevitz J, Hooper DC (2014) Plasmid-mediated quinolone resistance. Microbiol Spectr DOI:10.1128/microbiolspec.PLAS-0006-2013
Poirel L, Cattoir V, Nordmann P (2012) Plasmid mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol 3(24):1–7
Oliphant CM, Green GM (2002) Quinolones: a comprehensive review. Am Fam Physician 65:455–464
Paton JH, Reeves DS (1988) Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. Drugs 36:193–228
Redgrave LS, Sutton SB, Webber MA, Piddock LJV (2014) Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 22(8):438–445
Álvarez-Hernández DA, Garza-Mayén GS, Vázquez-López R (2015) Quinolonas. Perspectivas actuales y mecanismos de resistencia. Rev Chilena Infectol 32(5):499–504
Mohammadhosseini N, Pordeli M, Safavi M, Firoozpour L, Amin F, Kabudanian Ardestani S, Edraki N, Shafiee A, Foroumadi A (2015) Novel N-2-(furyl)-2-(chlorobenzyloxyimino) ethyl piperazinyl quinolones: synthesis, cytotoxic evaluation and structure-activity relationship. Iran J Pharm Res 14(4):1095–1103
Cross RM, Flanigan DL, Monastyrskyi A, LaCrue AN, Saenz FE, Maignan JR et al (2014) Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of plasmodium. J Med Chem 57:8860–8879
Boothe D, Boeckh A, Simpson B, Dubose K (2006) Comparison of pharmacodynamics and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats. J Vet Inter Med 20:1297–1306
Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(1):29–35
Kohanski MA, Dwyer DJ, Collins JJ (2010) How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8(6):423–435
Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51:1109–1117
Belenky P, Ye JD, Porter CBM, Cohen NR, Lobritz MA, Ferrantee T et al (2015) Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage. Cell Rep 13(5):968–980
Kottur J, Nair DT (2016) Reactive oxygen species play an important role in the bactericidal activity of quinolone antibiotics. Angew Chem Int Ed Engl 55(7):2397–2400
Piddock LJ, Walters RN (1992) Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division. Antimicrob Agents Chemother 36:819–825
Yoshida H, Bogaki M, Nakamura M, Nakamura S (1990) Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 34:1271–1272
Barnard FM, Maxwell A (2001) Interaction between DNA gyrase and quinolones: effects of alanine mutations at gyrA subunit residues Ser83 and Asp87. Antimicrob Agents Chemother 45:1994–2000
Wohlkonig A, Chan PF, Fosberry AP, Homes P, Huang J, Kranz M et al (2010) Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 17:1152–1153
Laponogov I, Veselkov DA, Crevel IM, Pan XS, Fisher LM, Sanderson MR (2013) Structure of an ‘open’ clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport. Nucl Acids Res 41:9911–9923
Everett MJ, Jin YF, Ricci V, Piddock LJV (1996) Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40:2380–2386
Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jiménez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli strains. J Antimicrob Chemother 44:735–742
Ruiz J, Gómez J, Navia MM, Ribera A, Sierra JM, Marco F et al (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42(4):257–261
Aldred KJ, Schwanz HA, Li G, Williamson BH, McPherson SA, Turnbough CL Jr et al (2015) Activity of quinolone cp-115,955 against bacterial and human type II topoisomerases is mediated by different interactions. Biochemistry 54:1278–1286
Machuca J, Briales A, Labrador G, Díaz-de-Alba P, López-Rojas R, Docobo-Pérez F et al (2014) Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother 69(12):3203–3215
Piddock LJ (1999) Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58(2):11–18
Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S (1986) Isolation and characterization of norfloxacin resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 30:248–253
Komp Lindgren P, Marcusson LL, Sandvang D, Frimodt-Møller N, Hughes D (2005) Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 49:2343–2351
Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH et al (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12:83–88
Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato (2007) New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51(9):3354–3360
Hansen LH, Jensen LB, Sørensen HI, Sørensen SJ (2007) Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother 60:145–147
Yoshida H, Bogaki M, Nakamura M, Yamanaka LM, Nakamura S (1991) Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother 35:1647–1650
Breines DM, Ouabdesselam S, Ng EY, Tankovic J, Shah S, Soussy CJ, Hooper DC (1997) Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of parE gene encoding a subunit of topoisomerase IV. Antimicrob Agents Chemother 41:175–179
Chapman JS, Georgopapadokou NH (1988) Routes of quinolone permeation in Escherichia coli. Antimicrob Agents Chemother 32:438–442
Kang HW, Woo GJ (2014) Increase of multidrug efflux pump expression in fluoroquinolone-resistant Salmonella mutants induced by ciprofloxacin selective pressure. Res Vet Sci 97(2):182–186
Grkovic S, Brown MH, Skurray RA (2002) Regulation of bacterial drug export systems. Microbiol Mol Biol Rev 66:671–701
Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20–51
Alekshun MN, Levy SB (1997) Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 41:2067–2075
Yamasaki E, Yamada C, Jin X, Nair GB, Kurazono H, Yamamoto S (2015) Expression of marA is remarkably increased from the early stage of development of fluoroquinolone-resistance in uropathogenic Escherichia coli. J Infect Chemother 21(2):105–109
Chou JH, Greenberg JT, Demple B (1998) Postranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus. J Bacteriol 175:1026–1031
Aoyama H, Sato K, Kato T, Hirai K, Mitsuhashi S (1987) Norfloxacin resistance in a clinical isolate of Escherichia coli. Antimicrob Agent Chemother 31:1640–1641
Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB (1989) Cross-resistance to fluoroquinolone in multiple-antibiotic-resistance (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 33:1318–1325
Mitsuyama J, Itoh Y, Takahata M, Okamoto S, Yasuda T (1992) In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis and Salmonella typhimurium. Antimicrob Agents Chemother 36:2030–2036
Martínez-Martínez L, Pascual A, Jacoby GA (1998) Quinolone resistance from a transferable plasmid. Lancet 351:797–799
Tran JH, Jacoby GA, Hooper DC (2005) Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob Agents Chemother 49(7):3050–3052
Vetting MW, Hedge SS, Fajardo JE, Fiser A, Roderick SL, Takiff HE et al (2006) Pentapeptide repeat proteins. Biochemistry 45:1–10
Garrido MC, Herrero M, Kolter R, Moreno F (1988) The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J 7(6):1853–1862
Tran JH, Jacoby GA (2002) Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci 99:5638–5642
Hata M, Suzuki M, Matsumoto M, Takahashi M, Sato K, Ibe S et al (2005) Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49:801–803
Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A et al (2006) qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 50(4):1178–1182
Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S et al (2009) New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 53:1892–1897
Cavaco LM, Hasman H, Xia S, Aarestrup FM (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 53:603–608
Xia R, Guo X, Zhang Y, Xu H (2010) qnrVC-like gene located in a novel complex class 1 integron harboring the ISCR1 element in an Aeromonas punctata strain from an aquatic environment in Shandong Province, China. Antimicrob Agents Chemother 54:3471–3474
Singh R, Rajpara N, Tak J, Patel A, Mohanty P, Vinothkumar K et al (2012) Clinical isolates of Vibrio fluvialis from Kolkata, India, obtained during 2006: plasmids, the qnr gene and a mutation in gyrase A as mechanisms of multidrug resistance. J Med Microbiol 61:369–374
Fonseca EL, Dos Santos Freitas F, Vieira VV, Vicente AC (2008) New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect Dis 14:1129–1131
Rodriguez-Martinez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A (2011) Plasmid-mediated quinolone resistance: an update. J Infect Chemother 17:149–182
Poirel L, Rodriguez-Martinez JM, Mammeri H, Liard A, Nordmann P (2005) Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 49:3523–3525
Cattoir V, Poirel L, Mazel D, Soussy CJ, Nordmann P (2007) Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob Agents Chemother 51:2650–2651
Jacoby GA, Griffin CM, Hooper DC (2011) Citrobacter spp.as a source of qnrB alleles. Antimicrob Agents Chemother 55:4979–4984
Guillard T, Grillon A, De Champs C, Cartier C, Bercot B, Lebreil AL (2014) Mobile insertion cassette elements found in small nontransmissible plasmids in Proteeae may explain qnrD mobilization. PLoS One 9(2):1–8
Malik M, Zhao X, Drlica K (2006) Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol Microbiol 61:810–825
Baharoglu Z, Mazel D (2014) SOS, the formidable strategy of bacteria against aggressions. FEMS Microbiol Rev 38(6):1126–1145
Wang M, Jacoby GA, Mills DM, Hoope DC (2009) SOS regulation of qnrB expression. Antimicrob Agents Chemother 53(2):821–823
Briales A, Rodriguez-Martinez JM, Velasco C, Machuca J, Dìaz de Alba P, Blazquez J et al (2012) Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulation. Antimicrob Chemother 67:2854–2859
Da Re S, Garnier F, Guérin E, Campoy S, Denis F, Ploy MC (2009) The SOS response promotes qnrB quinolone-resistance expression. EMBO Rep 10(8):929–933
Little JW, Edmiston SH, Pacelli LZ, Mount DW (1980) Cleavage of the Escherichia coli lexA protein by the recA protease. Proc Natl Acad Sci U S A 77:3225–3229
Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A (2009) Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22:664–689
Robicsek A, Jacoby GA, Hooper DC (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6:629–640
Perichon B, Courvalin P, Galimand M (2007) Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother 51:2464–2469
Cattoir V, Poirel L, Nordmann P (2008) Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob Agents Chemother 52:3801–3804
Wang D, Huang X, Chen J, Mou Y, Li H, Yang L (2015) Characterization of genetic structures of the qepA3 gene in clinical isolates of Enterobacteriaceae. Front Microbiol 6:1147
Hansen LH, Johannesen E, Burmølle M, Sørensen AH, Sørensen SJ (2004) Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob Agents Chemother 48:3332–3337
Norman A, Hansen LH, She Q, Sørensen SJ (2008) Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid 60:59–74
Rodriguez-Martinez JM, Diaz de Alba P, Briales A, Machuca J, Lossa M, Fernandez-Cuenca F et al (2013) Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-ß-lactamase-producing Klebsiella pneumoniae. Antimicrob Chemother 68:68–73
Wong MH, Chan EW, Chen S (2015) Evolution and dissemination of OqxAB-like efflux pumps, an emerging quinolone resistance determinant among members of Enterobacteriaceae. Antimicrob Agents Chemother 59(6):3290–3297
Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneidersa T (2012) Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 56(8):4450–4458
Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S et al (2015) Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother 70(1):81–88
Drlica K (2003) The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 52:11–17
Zhao X, Drlica K (2001) Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 33(3):S147–S156
Rodríguez-Martínez JM, Velasco C, García I, Cano ME, Martínez-Martínez L, Pascual A (2007) Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother 51(6):2236–2239
Machuca J, Briales A, Díaz-de-Alba P, Martínez-Martínez L, Pascual Á, Rodríguez-Martínez JM (2015) Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother 70(9):2524–2527
Guillard T, Cambau E, Chau F, Massias L, de Champs C, Fantin B (2013) Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6′)-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro. Antimicrob Agent Chemother 57(12):5830–5835
Machuca J, Ortiz M, Recacha E, Díaz-De-Alba P, Docobo-Perez F, Rodríguez-Martínez JM et al (2016) Impact of AAC(6′)-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli. J Antimicrob Chemother 71(11):3066–3071
Michon A, Allou N, Chau F, Podglajen I, Fantin B, Cambau E (2011) Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure. PLoS One 6(9):e24552
Vinué L, Corcoran MA, Hooper DC, Jacoby GA (2016) Mutations that enhance the ciprofloxacin resistance of Escherichia coli with qnrA1. Antimicrob Agents Chemother 60(3):1537–1545
Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R et al (2008) Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 62:133–136
Meradi L, Djahoudi A, Abdi A, Bouchakour M, Perrier Gros Claude JD, Timinouni M (2011) Qnr and aac(6′)-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria. Pathol Biol 59(4):e73–e78
Agabou A, Lezzar N, Ouchenane Z, Khemissi S, Satta D, Sotto A et al (2015) Clonal relationship between human and avian ciprofloxacin-resistant Escherichia coli isolates in North-Eastern Algeria. Eur J Clin Microbiol Infect Dis 35(2):227–234
Yanat B, Machuca J, Díaz-De-Alba P, Mezhoud H, Touati A, Pascual Á et al (2016) Characterization of plasmid-mediated quinolone resistance determinants in high-level quinolone-resistant Enterobacteriaceae isolates from the community: First report of qnrD gene in Algeria. Microb Drug Resist DOI: 10.1089/mdr.2016.0031
Anssour L, Messai Y, Estepa V, Torres C, Bakour R (2016) Characteristics of ciprofloxacin-resistant Enterobacteriaceae isolates recovered from wastewater of an Algerian hospital. J Infect Dev Ctries 10(7):728–734
Literacka E, Bedenic B, Baraniak A, Fiett J, Tonkic M, Jajic-Bencic I et al (2009) bla CTX-M genes in Escherichia coli strains from Croatian hospitals are Located in new (bla CTX-M-3a) and widely spread (bla CTX-M-3a and bla CTX-M-15 ) genetic structures. Antimicrob Agents Chemother 4(53):1630–1635
Ishida Y, Ahmed AM, Mahfouz NB, Kimura T, El-Khodery SA, Moawad AA et al (2010) Molecular analysis of antimicrobial resistance in Gram-negative bacteria isolated from fish farms in Egypt. J Vet Med Sci 72(6):727–734
Hassan WM, Hashim A, Domany RAA (2012) Plasmid mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr, and qepA in ESBL producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol 30(4):442–447
Abd El-Aziz NK, Gharib AA (2015) Coexistence of plasmid-mediated quinolone resistance determinants and AmpC-Beta-Lactamases in Escherichia coli strains in Egypt. Cell Mol Biol 61(5):29–35
Poirel L, Leviandier C, Nordmann P (2006) Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French University Hospital. Antimicrob Agent Chemother 50(12):3992–3997
Cambau E, Lascols C, Sougakoff W, Bebear C, Bonnet R, Cavallo JD et al (2006) Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005. Clin Microbiol Infect 12:1013–1020
Guillard T, Cholley P, Limelette A, Hocquet D, Matton L, Guyeux C et al (2015) Fluoroquinolone resistance mechanisms and population structure of Enterobacter cloacae non-susceptible to ertapenem in North-Eastern France. Front Microbiol 6:1186
Mavroidi A, Miriagou V, Liakopoulos A, Tzelepi E, Stefos A, Dalekos GN et al (2012) Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis 12:371–376
Chmelnitsky I, Hermesh O, Navon-Venezia S, Strahilevitz J, Carmeli Y (2009) Detection of aac(6′)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J Antimicrob Chemother 64:718–722
Musumeci R, Rausa M, Giovannoni R, Cialdella A, Bramati S, Sibra B et al (2012) Prevalence of plasmid-mediated quinolone resistance genes in uropathogenic Escherichia coli isolated in a teaching hospital of northern Italy. Microb Drug Resist 18(1):33–41
Donati V, Feltrin F, Hendriksen RS, Aaby Svendsen C, Cordaro G, Garcia-Fernandez A (2014) Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in Klebsiella spp. from companion animals in Italy. PloS One 9(3):e90564
Bouchakour M, Zerouali K, Perrier Gros Claude JD, Amarouch H, El Mdaghri N, Courvalin P et al (2010) Plasmid-mediated quinolone resistance in expanded spectrum beta-lactamase producing Enterobacteriaceae in Morocco. J Infect Dev Ctries 4(12):799–803
Barguigua A, Ouair H, El Otmani F, Saile R, El Mdaghri N, El Azhari M et al (2015) Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca. Infect Dis 47(1):27–32
Barguigua A, Zerouali K, Katfy K, El Otmani F, Timinouni M, Elmdaghri N (2015) Occurrence of OXA-48 and NDM-1 carbapenemase-producing Klebsiella pneumoniae in a Moroccan university hospital in Casablanca. Morocco Infect Genet Evol 31:142–148
Tayh G, Ben Sallem R, Ben Yahia H, Gharsa H, Klib N, Boudabous A et al (2016) First report of extended-spectrum β-lactamases among clinical isolates of Klebsiella pneumoniae in Gaza strip, Palestine. Microb Drug Resist DOI: 10.1089/mdr.2016.0089
Cano ME, Rodrìguez-Martìnez JM, Aguero J, Pascual A, Calvo J, Garcìa-Lobo JM et al (2009) Detection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J Clin Microbiol 47(7):2033–2039
Briales A, Rodríguez-Martínez JM, Velasco C, de Alba PD, Rodríguez-Baño J, Martínez-Martínez L et al (2012) Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Int J Antimicrob Agents 39(5):431–434
Pérez-Moreno MO, Picó-Plana E, De Toro M, Grande-Armas J, Quiles-Fortuny V, Pons MJ et al (2013) β-Lactamases, transferable quinolone resistance determinants, and class 1 integron-mediated antimicrobial resistance in human clinical Salmonella enterica isolates of non-Typhimurium serotypes. Int J Med Microbiol 303(1):25–31
Machuca J, Agüero J, Miró E, Conejo MD, Oteo J, Bou G et al (2016) Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain. Enferm Infecc Microbiol Clin DOI: 10.1016/j.eimc.2016.05.006
Dahmen S, Poirel L, Mansour W, Bouallegue O, Nordmann P (2010) Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia. Clin Microbiol Infect 16(7):1019–1021
Arpin C, Thabet L, Yassine H, Messadi AA, Boukadida J, Dubois V et al (2012) Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit. Antimicrob Agent Chemother 56(3):1342–1349
Mnif B, Ktari S, Chaari A, Medhioub F, Rhimi F, Bouaziz M et al (2013) Nosocomial dissemination of Providencia stuartii isolates carrying bla OXA-48 , bla PER-1 , bla CMY-4 and qnrA6 in a Tunisian hospital. J Antimicrob Chemother 68:329–332
Mahrouki S, Perilli M, Bourouis A, Chihi H, Ferjani M, Ben Moussa M et al (2013) Prevalence of quinolone resistance determinant qnrA6 among broad- and extended-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integron association in a Tunisian Hospital. Scand J Infect Dis 45(8):600–605
Avsaroglu MD, Helmuth R, Junker E, Hertwig S, Schroeter A, Akcelik M et al (2007) Plasmid-mediated quinolone resistance conferred by qnrS1 in Salmonella enterica serovar Virchow isolated from Turkish food of avian origin. J Antimicrob Chemother 60:1146–1150
Nazik H, Öngen B, Mete B, Aydin S, Yemisen M, Kelesoglu FM et al (2011) Coexistence of bla OXA-48 and aac(6′)-Ib-cr genes in Klebsiella pneumoniae isolates from Istanbul, Turkey. J Int Med Res 39:1932–1940
Nazik H, Ongen B, Kuvat N (2008) Investigation of plasmid-mediated quinolone resistance among isolates obtained in a Turkish intensive care unit. Jpn J Infect Dis 61:310–312
Pelrano G, Van der Bi AK, Freeman JL, Poirel L, Nordmann P, Costello M et al (2014) Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum-lactamases: global distribution of the H30-Rx sublineage. Antimicrob Agent Chemother 58(73):3762–3767
Loncaric I, Beiglböck C, Febler AT, Posautz A, Rosengarten R, Walzer C et al (2016) Characterization of ESBL- and AmpC-producing and fluoroquinolone-resistant Enterobacteriaceae isolated from Mouflons (Ovis orientalis musimon) in Austria and Germany. PLoS One 11(5):e0155786
Cattoir V, Nordmann P, Silva-Sanchez J, Espinal P, Poirel L (2008) ISEcp1-mediated transposition of qnrB-Like gene in Escherichia coli. Antimicrob Agents Chemother 52(8):2929–2932
Kehrenberg C, Hopkins KL, Threlfall EJ, Schwarz S (2007) Complete nucleotide sequence of a small qnrS1-carrying plasmid from Salmonella enterica subsp. enterica Typhimurium DT193. J Antimicrob Chemother 60:903–905
Ruiz E, Saénz Y, Zarazaga M, Rocha-Gracia R, Martìnez-Martìnez L, Arlet G et al (2012) qnr, aac(6′)-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. J Antimicrob Chemother 67:886–897
Deng YT, Zeng ZL, Tian W, Yang T, Liu JH (2013) Prevalence and characteristics of rmtB and qepA in Escherichia coli isolated from diseased animals in China. Front Microbiol 4:198
Onuk EE, Tanrıverdi Çaycı Y, Çoban AY, Çiftci A, Balta F, Didinen BI et al (2015) Detection of the first qnrS gene positivity in aquatic Aeromonas spp. isolates in Turkey. Mikrobiyol Bul 49(1):114–123
Yang H, Hu L, Liu Y, Ye Y, Li J (2016) Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China. J Chemother 22:1–3
Yang X, Xing B, Liang C, Ye Z, Zhang Y (2015) Prevalence and fluoroquinolone resistance of Pseudomonas aeruginosa in a hospital of South China. Int J Clin Exp Med 8(1):1386–1390
Filippa N, Carricajo A, Grattard F, Fascia P, El Sayed F, Defilippis JP et al (2013) Outbreak of multidrug-resistant Klebsiella pneumoniae carrying qnrB1 and bla CTX-M15 in a French intensive care unit. Ann Intensive Care 3(1):18
Ferjani S, Saidani M, Quentin C, Slim Amine F, Boutiba Ben Boubaker I, Dubois V (2014) Prevalence and characterization of uropathogenic Escherichia coli harboring plasmid-mediated quinolone resistance in a Tunisian university hospital. Diagn Microbiol Infect Dis 79(2):247
Longhi C, Conte MP, Marazzato M, Iebba V, Totino V, Santangelo FC et al (2012) Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance. Eur J Clin Microbiol Infect Dis 31(8):1917–1921
Dotto G, Giacomelli M, Grilli G, Ferrazzi V, Carattoli A, Fortini D et al (2014) High prevalence of oqxAB in Escherichia coli isolates from domestic and wild lagomorphs in Italy. Microb Drug Resist 20(2):118–123
Guillard T, de Jong A, Limelette A, Lebreil AL, Madoux J, de Champs C et al (2016) Characterization of quinolone resistance mechanisms in Enterobacteriaceae recovered from diseased companion animals in Europe. Vet Microbiol 194:23–29
Yousfi M, Mairi A, Touati A, Hassissene L, Brasme L, Guillard T et al (2016) Extended spectrum β-lactamase and plasmid mediated quinolone resistance in Escherichia coli fecal isolates from healthy companion animals in Algeria. J Infect Chemother 22(7):431–435
Ghodousi A, Bonura C, Di Noto AM, Mammina C (2015) Extended-spectrum ß-Lactamase, AmpC-producing, and fluoroquinolone-resistant Escherichia coli in retail broiler chicken meat, Italy. Foodborne Pathog Dis 12(7):619–625
Alouache S, Estepa V, Messai Y, Ruiz E, Torres C, Bakour R (2014) Characterization of ESBLs and associated quinolone resistance in Escherichia coli and Klebsiella pneumoniae isolates from an urban wastewater treatment plant in Algeria. Microb Drug Resist 20:30–38
Anssour L, Messai Y, Derkaoui M, Alouache S, Estepa V, Somalo S et al (2014) ESBL, plasmidic AmpC, and associated quinolone resistance determinants in coliforms isolated from hospital effluent: first report of qnrB2, qnrB9, qnrB19, and bla CMY-4 in Algeria. J Chemother 26(2):74–79
Ahmed AM, Shimamoto T (2011) Molecular characterization of antimicrobial resistance in Gram-negative bacteria isolated from bovine mastitis in Egypt. Microbiol Immunol 55(5):318–327
Cubero M, Calatayud L, Tubau F, Ayats J, Peña C, Martín R et al (2013) Clonal spread of Klebsiella pneumoniae producing OXA-1 betalactamase in a Spanish hospital. Int Microbiol 16:227–233
Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1–14
Brahmi S, Dunyach-Rémy C, Touati A, Lavigne JP (2015) CTX-M-15-producing Escherichia coli and the pandemic clone O25b-ST131 isolated from wild fish in Mediterranean Sea. Clin Microbiol Infect 21:e18–e20
Lunn AD, Fàbrega A, Sánchez-Céspedes J, Vila J (2010) Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates. Int Microbiol 13:15–20
Al-Gallas N, Abbassi MS, Gharbi B, Manai M, Ben Fayala MN, Bichihi R et al (2013) Occurrence of plasmid-mediated quinolone resistance determinants and rmtB gene in Salmonella enterica serovar enteritidis and Typhimurium isolated from food- animal products in Tunisia. Foodborne Pathog Dis 10(9):813–819
Zhao J, Chen Z, Chen S, Deng Y, Liu Y, Tian W et al (2010) Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother 54(10):4219–4224
Buruk CK, Öztel Ocak H, Bayramoğlu G, Aydın F (2016) Investigation of plasmid-mediated quinolone resistance genes in quinolone-resistant Escherichia coli and Klebsiella spp. isolates from bloodstream infections. Mikrobiyol Bul 50(2):186–195
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None to declare.
Funding
None to declare.
Rights and permissions
About this article
Cite this article
Yanat, B., Rodríguez-Martínez, JM. & Touati, A. Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. Eur J Clin Microbiol Infect Dis 36, 421–435 (2017). https://doi.org/10.1007/s10096-016-2847-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2847-x